Jara-Sánchez, Carlos <br/><br/>
Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.  [electronic resource] 

 -  Clinical breast cancer  Feb 2003 
 - 399-404 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1526-8209 
<br/><br/><label>Standard No.: </label>10.3816/cbc.2003.n.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Survival Analysis<br/>Treatment Outcome<br/>Vinblastine--administration & dosage<br/>Vinorelbine